Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-07
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • br Hedgehog pathway in embryonic development It is

    2021-09-10


    Hedgehog pathway in embryonic development It is now well established that the Hedgehog pathway solves a role as one of the essential signaling mechanisms for the modulation of cellular growth and differentiation during embryogenesis. Operating through time- and position-dependent mechanisms, this pathway mostly guarantees the correct size, cellular content and position achievement of organs during embryonic development [24]. As a mitogen, the Sonic Hedgehog signaling pathway promotes proliferative and differentiation processes in specific groups of 28170 from ectoderm, mesoderm and endoderm tissues [[25], [26], [27], [28]]. In addition, this pathway is involved in the formation of teeth and lungs and midline facial development, and most importantly the induction of neural tissue by mesodermal notochord [29]. Beside its regulatory role on cell proliferation, Sonic Hedgehog can also promote proliferation and survival of neural progenitor cells in the ventral spinal cord [30]. This pathway controls different sets of homeodomain proteins in distinct progenitor cells through utilization of GliA and GliR [31]. GliA and GliR similarly affect a wide range of targets during Sonic Hedgehog induced development of sclerotome. Nevertheless, the way through which the expression of these sets of target genes is regulated is yet to be fully understood. Through regulating the proliferation and differentiation of chondrocytes, the Indian Hedgehog signaling pathway mostly controls skeletal development during embryogenesis. Additionally, the pathway is involved in visceral endoderm differentiation, hematopoiesis and vasculogenesis [32]. Finally, the Schwann cell derived Desert Hedgehog signaling pathway results in the creation of perineurium through induction of mesenchymal cell transitions [33].
    Key components of the Hedgehog pathway in vertebrates The vital physiological roles of the Hh signaling pathway has inspired many scientists to investigate its key components and the interplay between them. This complicated signaling mechanism regulates proliferation, differentiation, and tissue patterning during embryogenesis and can be reactivated in adults as part of processes of repair and regeneration [34]. So far, canonical (mediated by Gli family of transcription factors) together with non-canonical pathways (mediated by Gli independent mechanisms) have been proposed for Hh protein signal transduction which is mostly enriched in the cilia. Prior to secretion, all Hh proteins undergo covalent attachment of a cholesterol molecule to the C-terminal residue, after which Hh acyltransferase (Hhat) transfers a palmitoyl group to the amino termini. These lapidated morphogens are secreted to the cell surface, where they undergo a multimerization process; in this form they interact with Hh receptors, serving as long range signaling molecules [[35], [36], [37]]. Sheddases such as the glycoprotein Scube2 (signal peptide, cubulin domain, epidermal growth factor-like protein 2) and glycosylphosphatidylinositol (GPI)-linked glypican (Gpc) heparan sulfate proteoglycans (HSPGs) have been proven to be regulators of Hh activity. Grobe and colleagues proposed that Gpc HSPG control the release of SHh from secreting cells in preclinical models, where purified heparane sulfate has been found to directly trigger SHh processing [37]. Other approaches have shown that Hhat, the enzyme responsible for the transfer of palmitate upon SHh, could function as a potent therapeutic target in pancreatic cancer [38]. Magee and colleagues offer significant insights regarding Hhat activity and structure, with potential benefits for a more informed development of Hhat targeting agents. They reveled that the enzyme is composed of ten transmemebrane domains and is palmitoylated on numerous cysteines with cytosolic localization, which aids in structural stability. Furthermore, mutation within the catalytic domain can result in complete depletion of Hhat palmitoylation [39].